Hemostasis Diagnostics Market, By Test (Prothrombin time test, Fibrinogen test, D-dimer test, and Activated partial thromboplastin time test), By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV4266
|
Published Date
August 2025
|
Pages
260
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Hemostasis Diagnostics Market size was valued at USD 1,190.23 Million in 2024, expanding at a CAGR of 4.59% from 2025 to 2032.
Hemostasis diagnostics refer to medical tests that assess the body’s ability to prevent and stop bleeding by evaluating the blood clotting (coagulation) system. These diagnostics are vital for detecting bleeding disorders, identifying clotting conditions such as thrombosis, and monitoring patients on anticoagulant (blood-thinning) therapies. They are commonly used before surgeries, during long-term medication management, and in the treatment of inherited or acquired coagulation abnormalities. The rising global burden of cardiovascular and blood disorders is driving the need for advanced hemostasis testing. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. In response, governments worldwide are increasing investments in diagnostic infrastructure and public health initiatives. For example, the European Union’s Horizon Europe program and the U.S. National Institutes of Health (NIH) have allocated funding for research and development in coagulation diagnostics and patient monitoring, further boosting innovation and access to these critical healthcare tools.
Hemostasis Diagnostics Market- Market Dynamics
Rising Prevalence of Chronic and Blood Disorders to Drive Hemostasis Diagnostics Market Growth
The hemostasis diagnostics market is witnessing strong growth, driven by the rising prevalence of bleeding and clotting disorders such as hemophilia, von Willebrand disease, thrombocytopenia, and deep vein thrombosis (DVT). According to the World Federation of Hemophilia, over 400,000 people globally live with hemophilia—many of whom require routine monitoring and testing, significantly contributing to market demand. Additionally, chronic conditions like cardiovascular disease, liver disorders, and cancer often necessitate regular coagulation testing to manage risks of thrombosis or hemorrhage. For instance, chemotherapy in cancer patients can disrupt coagulation profiles, prompting the need for continuous diagnostic evaluation. The aging global population further fuels market growth, as older adults are more susceptible to coagulation-related issues and frequently require anticoagulant therapies for conditions such as atrial fibrillation or stroke prevention, particularly following surgical procedures. The increase in surgical procedures—especially orthopedic and cardiovascular surgeries—has also driven the need for pre-operative coagulation screening.
Government and health organization initiatives have elevated public and clinical awareness about early detection and management of coagulation disorders. This has led to increased screening and diagnostics, especially in developed and middle-income countries. In parallel, technological advancements—such as the adoption of viscoelastic testing methods like TEG (Thromboelastography) and ROTEM (Rotational Thromboelastometry)—are transforming coagulation monitoring. These technologies offer real-time, dynamic insights into clot formation and dissolution, enabling more precise and timely clinical decisions in surgery, trauma, and critical care settings. These combined factors are positioning hemostasis diagnostics as an essential component of modern healthcare, with growing relevance across hospitals, laboratories, and point-of-care environments.
Hemostasis Diagnostics Market- Key Insights
- According to analysis from our research team, the global hemostasis diagnostics market is projected to grow at a compound annual growth rate (CAGR) of approximately 4.59% between 2024 and 2032.
- By test type, the prothrombin time test segment is expected to hold the largest market share in 2024, attributed to its ease of use, cost-effectiveness, and minimal training requirements.
- In terms of product type, the consumables segment led the market in 2024, driven by increasing healthcare access and the ongoing demand for disposable testing materials worldwide.
- Hospitals emerged as the dominant end-user segment in 2024, reflecting the critical need for diagnosis and management of coagulation disorders in clinical settings.
- Regionally, North America generated the highest revenue in 2024, largely due to the high prevalence of conditions such as venous thrombosis and atrial fibrillation in the area.
Hemostasis Diagnostics Market- Segmentation Analysis:
The Global Hemostasis Diagnostics Market is segmented on the basis of Test, Product Type, End User, and Region.
The coagulation testing market is segmented based on test types into prothrombin time test, fibrinogen test, D-dimer test, activated partial thromboplastin time test, and others. Among these, the prothrombin time test segment dominates the market, driven by the increasing prevalence of bleeding disorders and liver diseases globally. Governments and health organizations, including the World Health Organization (WHO), are prioritizing early diagnosis and management of coagulation disorders, allocating significant funding to improve diagnostic infrastructure and awareness programs, which is expected to further propel demand for prothrombin time testing worldwide.
Based on product type, the market is divided into consumables, laboratory analyzers, and point-of-care (PoC) testing systems. The consumables segment holds the largest market share due to their essential role in coagulation testing accuracy and the consistent need for reagents and test kits to maintain standard diagnostic results. Many governments are investing in strengthening laboratory capacities, with initiatives from agencies like the U.S. Centers for Disease Control and Prevention (CDC) emphasizing the importance of reliable consumables supply chains to ensure uninterrupted diagnostic services, particularly in low- and middle-income countries.
Regarding end users, the market is categorized into hospitals, diagnostic laboratories, and others. Hospitals dominate the market and are expected to maintain this position during the forecast period, fueled by the growing demand for coagulation testing in critical care and emergency settings where rapid and accurate diagnostics are crucial. Public health authorities globally are enhancing hospital diagnostic capabilities as part of broader healthcare improvement strategies, with the Global Fund reporting increased investments in hospital-based diagnostic technologies to better manage acute conditions, which supports sustained market growth in this segment.
Hemostasis Diagnostics Market- Competitive Landscape:
The hemostasis diagnostics market is highly competitive and technology-driven, featuring a mix of global diagnostic leaders, regional players, and specialized medical device companies. To expand their market presence and share, companies are focusing on strategic partnerships, mergers, and continuous product innovation. There is a growing emphasis on developing portable hemostasis diagnostic devices designed for near-patient testing, particularly in emergency rooms and surgical environments. For instance, Beckman Coulter and Roche are investing in integrated digital platforms that facilitate multi-diagnostic data management.
Recent Developments:
- In April 2024, Haemonetics Corporation received U.S. FDA clearance for its Global Hemostasis-HN assay cartridge.
- In September 2024, Sysmex Corporation launched the HISCL HIT IgG Assay Kit, which detects IgG antibodies in patients undergoing heparin therapy.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMOSTASIS DIAGNOSTICS MARKET KEY PLAYERS
- Siemens Healthineers
- Roche Diagnostics
- Sysmex Corporation
- Werfen Group
- Abbott Laboratories
- Thermo Fisher Scientific
- Beckman Coulter
- Diagnostica Stago
- HemoSonics (Stago Group)
- Horiba Medical
- Trinity Biotech
- Helena Laboratories
- BioMérieux
- BD
- Grifols S.A.
- Medtronic
- Others
GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY TEST- MARKET ANALYSIS, 2019-2032
- Prothrombin time test
- Fibrinogen test
- D-dimer test
- Activated partial thromboplastin time test
- Others
GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
- Consumables
- Laboratory analyzers
- PoC testing systems
GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
- Hospitals
- Diagnostic laboratories
- Others
GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hemostasis Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hemostasis Diagnostics Market Snippet by Test
2.1.2. Hemostasis Diagnostics Market Snippet by Product Type
2.1.3. Hemostasis Diagnostics Market Snippet by End User
2.1.4. Hemostasis Diagnostics Market Snippet by Country
2.1.5. Hemostasis Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Hemostasis Diagnostics Key Market Trends
3.1. Hemostasis Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hemostasis Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hemostasis Diagnostics Market Opportunities
3.4. Hemostasis Diagnostics Market Future Trends
4. Hemostasis Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hemostasis Diagnostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Hemostasis Diagnostics Market Landscape
6.1. Hemostasis Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hemostasis Diagnostics Market – By Test
7.1. Overview
7.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
7.1.2. Prothrombin time test
7.1.3. Fibrinogen test
7.1.4. D-dimer test
7.1.5. Activated partial thromboplastin time test
7.1.6. Others
8. Hemostasis Diagnostics Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Consumables
8.1.3. Laboratory analyzers
8.1.4. PoC testing systems
9. Hemostasis Diagnostics Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic laboratories
9.1.4. Others
10. Hemostasis Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Hemostasis Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Hemostasis Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Hemostasis Diagnostics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Hemostasis Diagnostics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Hemostasis Diagnostics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Hemostasis Diagnostics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Siemens Healthineers
11.2.2. Roche Diagnostics
11.2.3. Sysmex Corporation
11.2.4. Werfen Group
11.2.5. Abbott Laboratories
11.2.6. Thermo Fisher Scientific
11.2.7. Beckman Coulter
11.2.8. Diagnostica Stago
11.2.9. HemoSonics (Stago Group)
11.2.10. Horiba Medical
11.2.11. Trinity Biotech
11.2.12. Helena Laboratories
11.2.13. BioMérieux
11.2.14. BD
11.2.15. Grifols S.A.
11.2.16. Medtronic
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
